{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:25:23Z","timestamp":1790774723782,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0627"],"award-info":[{"award-number":["2022YFS0627"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110600","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T02:50:15Z","timestamp":1688698215000},"page":"110600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease"],"prefix":"10.1016","volume":"122","author":[{"given":"Yan","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1292-7236","authenticated-orcid":false,"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-8232","authenticated-orcid":false,"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110600_b0005","doi-asserted-by":"crossref","first-page":"e019853","DOI":"10.1161\/JAHA.120.019853","article-title":"Kawasaki disease with coronary artery lesions detected at initial echocardiography","volume":"10","author":"Ae","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2023.110600_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107037","article-title":"Value of C-reactive protein\/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China","volume":"89","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.110600_b0015","doi-asserted-by":"crossref","first-page":"e0176957","DOI":"10.1371\/journal.pone.0176957","article-title":"A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease","volume":"12","author":"Takeshita","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110600_b0020","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.2147\/JIR.S360802","article-title":"Risk factors and predictive models for intravenous immunoglobulin resistance in children with recurrent Kawasaki Disease","volume":"15","author":"Chen","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2023.110600_b0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41390-021-01459-w","article-title":"Comparison of IVIG resistance predictive models in Kawasaki disease","volume":"91","author":"Kaya Akca","year":"2022","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.intimp.2023.110600_b0030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12887-022-03533-6","article-title":"A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease","volume":"22","author":"Joung","year":"2022","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.intimp.2023.110600_b0035","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00380-021-01819-w","article-title":"Prognostic value of pretreatment prognostic nutritional index in intravenous immunoglobulin-resistant Kawasaki disease","volume":"36","author":"Li","year":"2021","journal-title":"Heart Vessels"},{"key":"10.1016\/j.intimp.2023.110600_b0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cca.2020.05.004","article-title":"Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease","volume":"507","author":"Li","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2023.110600_b0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cca.2017.05.019","article-title":"TNF-\u03b1 is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease","volume":"471","author":"Hu","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2023.110600_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12519-019-00234-6","article-title":"Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease","volume":"15","author":"Kong","year":"2019","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.intimp.2023.110600_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108253","article-title":"The novel cytokine Metrnl\/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblasts","volume":"208","author":"Bridgewood","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110600_b0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12031-009-9189-4","article-title":"Characterization of Meteorin\u2013an evolutionary conserved neurotrophic factor","volume":"39","author":"J\u00f8rgensen","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2023.110600_b0065","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41401-020-00529-9","article-title":"Involvement of the secreted protein Metrnl in human diseases","volume":"41","author":"Miao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2023.110600_b0070","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.4049\/jimmunol.1800435","article-title":"Meteorin-like\/Meteorin-\u03b2 Is a Novel Immunoregulatory Cytokine Associated with Inflammation","volume":"201","author":"Ushach","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110600_b0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jcmm.13915","article-title":"Serum Metrnl is associated with the presence and severity of coronary artery disease","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2023.110600_b0080","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/ecco-jcc\/jjz001","article-title":"The Adipokine Metrnl Ameliorates Chronic Colitis in Il-10-\/- Mice by attenuating mesenteric adipose tissue lesions during spontaneous colitis","volume":"13","author":"Zuo","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.intimp.2023.110600_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cca.2022.11.021","article-title":"Increased serum IL-41 is associated with disease activity in rheumatoid arthritis","volume":"538","author":"Gong","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2023.110600_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2023.104478","article-title":"Plasma interleukin-41 serves as a potential diagnostic biomarker for Kawasaki disease","volume":"147","author":"Cai","year":"2023","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.intimp.2023.110600_b0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/1744666X.2017.1232165","article-title":"Kawasaki disease: etiopathogenesis and novel treatment strategies","volume":"13","author":"Agarwal","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.intimp.2023.110600_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.697632","article-title":"Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease","volume":"9","author":"Chang","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.intimp.2023.110600_b0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10238-018-00544-5","article-title":"Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm","volume":"19","author":"Wu","year":"2019","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110600_b0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/all.12558","article-title":"Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease","volume":"70","author":"Guo","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2023.110600_b0115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1253\/circj.CJ-09-0801","article-title":"IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease","volume":"74","author":"Weng","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.intimp.2023.110600_b0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jcsm.12865","article-title":"Serum Meteorin-like is associated with weight loss in the elderly patients with chronic heart failure","volume":"13","author":"Cai","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.intimp.2023.110600_b0125","doi-asserted-by":"crossref","first-page":"e24676","DOI":"10.1002\/jcla.24676","article-title":"Decreased serum interleukin-41\/Metrnl levels in patients with Graves' disease","volume":"36","author":"Gong","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.intimp.2023.110600_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101283","article-title":"Increased Expression of Meteorin-Like Hormone in Type 2 Diabetes and Obesity and Its Association with Irisin","volume":"8","author":"AlKhairi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.110600_b0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12969-017-0149-1","article-title":"Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease","volume":"15","author":"Xie","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.intimp.2023.110600_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.607631","article-title":"C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease","volume":"8","author":"Tsai","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.intimp.2023.110600_b0145","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrmicro1853","article-title":"Searching for the cause of Kawasaki disease\u2013cytoplasmic inclusion bodies provide new insight","volume":"6","author":"Rowley","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2023.110600_b0150","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","article-title":"Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis","volume":"157","author":"Rao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2023.110600_b0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2014.11.006","article-title":"METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages","volume":"156","author":"Ushach","year":"2015","journal-title":"Clin. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:23:51Z","timestamp":1736432631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923009256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":31,"alternative-id":["S1567576923009256"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110600","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110600"}}